Xylazine: Zombie Drug Provides a Wakeup Call for the Dangers of Drug Abuse
DOI:
https://doi.org/10.56570/jimgs.v2i1.77Keywords:
Xylazine, Veterinary tranquilizer, Drug abuse, Public health, Morbidity, Overdose preventionAbstract
Xylazine, the “Zombie Drug, is a scheduled class 3 controlled substance authorized for veterinary use. However, it is now increasingly being used as an adulterant with opioids to intensify their effect. The drug’s ready availability and addictive potential have made it popular among drug users. In our article we have portrayed the implications of Xylazine abuse and the need to be proactive in safeguarding against its abuse. Recent reports have shown a surge in Xylazine use in major cities in the United State causing to emerge as a public health threat. Symptoms include skin ulcerations, rotting, limb amputations, and blackouts. With no readily available antidote, effort must be taken to get the drug off the streets and prevent overdoses. There is a need for rigorous action, increase in budget and personnel to begin to overcome this rapidly rising public health threat.References
National Institute on Drug Abuse: Xylazine. (2022). Accessed: March 24, 2023: https://nida.nih.gov/research-topics/xylazine
GREENE SA, THURMON JC. Xylazine – a review of its pharmacology and use in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics.1988, 11(4):295–313. 10.1111/j.1365-2885.1988.tb00189.x
DEA Joint Intelligence Report: The growing threat of xylazine and its mixture with illicit drugs. (2022). Accessed: March 24, 2023: https://www.dea.gov/sites/default/files/2022-12/The%20Growing%20Threat%20of%20Xylazine%20and%20its%20Mixture%20with%20Illicit%20Drugs.pdf
Tranq Dope: Animal sedative mixed with Fentanyl brings fresh horror to U.S. drug zones. (2023). Accessed: March 24, 2023: https://www.nytimes.com/2023/01/07/health/fentanyl-xylazine-drug.html
FDA: FDA warns about the risk of xylazine exposure in humans. (2022). Accessed: March 24, 2023: https://www.fda.gov/media/162981/download
Reyes JC, Negrón JL, Colón HM, et al. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health. 2012, 89(3):519-526. 10.1007/s11524-011-9662-6
Xylazine in humans: Congress moves to make 'tranq' drug a controlled substance. (2023). Accessed: May 4, 2023: https://abc7ny.com/xylazine-effects-in-humans-congress-controlled-substance/13043734/
Kariisa M, Patel P, Smith H, Bitting J. Notes from the Field: Xylazine Detection and Involvement in Drug Overdose Deaths — United States, 2019. MMWR Morbidity and Mortality Weekly Report. 2021;70(37):1300-1302. Accessed:May 5, 2023: 10.15585/mmwr.mm7037a4